ONCY: Initiating Coverage of Oncolytics Biotech; A Focused Path to Unlocking the Potential of Pelareorep By David Bautz, PhDNASDAQ: ONCYREAD THE FULL ONCY RESEARCH REPORTWe are initiating coverage of Oncolytics Biotech (NASDAQ: ONCY) with a…
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality Issued on behalf of Oncolytics Biotech Inc. Issued on behalf of Oncolytics Biotech Inc.…
Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock? Oncolytics Biotech (ONCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects.…
Neue Möglichkeiten der Krebsbehandlung durch hochmoderne Immuntherapien Vancouver, Bc (ots/PRNewswire) - Veröffentlicht im Auftrag von Oncolytics Biotech Inc.USA News Group Nachrichtenkommentar - Die jüngsten Fortschritte in der…
Neue Möglichkeiten der Krebsbehandlung durch hochmoderne Immuntherapien USA News Group: Vancouver, Bc (ots/PRNewswire) - Veröffentlicht im Auftrag von Oncolytics Biotech Inc. USA News Group Nachrichtenkommentar – Die…
Oncolytics Biotech (TSE:ONC) Share Price Passes Below Two Hundred Day Moving Average of $1.50 Oncolytics Biotech (TSE:ONC) Stock Price Passes Below 200 Day Moving Average of $1.50…
Earnings call: Oncolytics Biotech reports progress and plans for pelareorep By Investing.com Earnings call: Oncolytics Biotech reports progress and plans for pelareorep…